Double trouble: Psychiatric comorbidity and opioid addiction—All-cause and cause-specific mortality-Reference-Cited by-同舟云学术

Double trouble: Psychiatric comorbidity and opioid addiction—All-cause and cause-specific mortality

Published:2015-03 Issue: Volume:148 Page:85-92
ISSN:0376-8716
Container-title:Drug and Alcohol Dependence
language:en
Short-container-title:Drug and Alcohol Dependence

Author:

Bogdanowicz Karolina M.,Stewart Robert,Broadbent Matthew,Hatch Stephani L.,Hotopf Matthew,Strang John,Hayes Richard D

Publisher

Elsevier BV

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology

Reference52 articles.

1. Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: a nationwide follow-up study of Danish substance users in treatment;Arendt;Drug Alcohol Depend.,2011

2. Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment;Arendt;J. Subst. Abuse Treat.,2007

3. Drug-related mortality and its impact on adult mortality in eight European countries;Bargagli;Eur. J. Public Health,2006

4. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers;Brooner;Arch. Gen. Psychiatry,1997

5. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients;Cacciola;Drug Alcohol Depend.,2001

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Challenges and Opportunities for Opioid Agonist Treatment Access and Retention: A Scoping Review;Journal of Drug Issues;2024-08-02

2. Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway;Addiction Science & Clinical Practice;2024-05-14

3. Unintended consequences of methadone regulation for opioid use disorder treatment among hospitalized patients;Journal of Hospital Medicine;2024-03-20

4. Multinational appraisal of the epidemiological distribution of opioid fatalities: a systematic review and meta-analysis;Frontiers in Psychiatry;2024-01-05

5. Experiences of serious depression and serious anxiety among individuals receiving injectable opioid agonist treatment (iOAT);Journal of Affective Disorders Reports;2024-01